Skip to main content
Clinical Trials/NCT05433519
NCT05433519
Completed
Not Applicable

Z 32104 - Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age

University of North Carolina, Chapel Hill2 sites in 2 countries400 target enrollmentJuly 27, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Age
Sponsor
University of North Carolina, Chapel Hill
Enrollment
400
Locations
2
Primary Endpoint
Diagnostic accuracy of FAMLI Technology
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a prospective cohort study of women enrolled early in pregnancy, with randomization to determine the timing of three follow-up visits in the second and third trimester. At each of these follow-up visits, investigators will assess gestational age with the FAMLI technology and compare that estimate to the known gestational age established early in pregnancy.

Detailed Description

The primary purpose of this research is to assess the diagnostic accuracy of the FAMLI Technology, a novel machine learning-based tool for gestational age assessment that can run on a smart phone or tablet. Study staff will enroll 400 pregnant volunteers prior to 14 completed gestational weeks and obtain accurate "ground truth" gestational age dating with standard ultrasound biometry, using the crown-rump length. These participants will then be asked to return for three follow-up visits, which will include a routine sonogram performed by a trained sonographer and the collection of a set of blind sweep cineloop videos using a low-cost, battery-operated device. The research will be conducted in Chapel Hill, North Carolina (at the University of North Carolina Hospital and/or sites associated with UNC OBGYN) and in Lusaka, Zambia (at the University Teaching Hospital or Kamwala District Health Centre). Approximately equal numbers of participants will be enrolled from each country.

Registry
clinicaltrials.gov
Start Date
July 27, 2022
End Date
November 13, 2023
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • viable intrauterine pregnancy at less than 14 0/7 weeks of gestation
  • ability and willingness to provide written informed consent
  • intent to remain in current geographical area of residence for the duration of study
  • willingness to adhere to study procedures
  • Exclusion criteria:
  • maternal body mass index = 40 kg/m\^2
  • multiple gestation (i.e., twins or higher order)
  • major fetal malformation or anomaly
  • any other condition (social or medical) that, in the opinion of the study staff, would make study participation unsafe or complicate data interpretation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Diagnostic accuracy of FAMLI Technology

Time Frame: From 14 through 27 completed weeks of gestation

Difference in mean absolute error (MAE) of the index test and clinical reference standard in the primary evaluation window

Secondary Outcomes

  • Mean absolute error in the secondary evaluation window(From 28 through 36 completed weeks of gestation)

Study Sites (2)

Loading locations...

Similar Trials